|
XB--978018
Papers associated with scn1a (and Disease Ontology)
???pagination.result.count???
???pagination.result.page??? 1
Sort Newest To Oldest | Sort Oldest To Newest |
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions., Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, Chebib M, McGregor IS, Arnold JC., Epilepsia. November 1, 2019; 60 (11): 2224-2234. |
|
A novel GABAergic dysfunction in human Dravet syndrome., Ruffolo G, Cifelli P, Roseti C, Thom M, van Vliet EA, Limatola C, Aronica E, Palma E., Epilepsia. November 1, 2018; 59 (11): 2106-2117. |
|
Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents., Gilchrist J, Dutton S, Diaz-Bustamante M, McPherson A, Olivares N, Kalia J, Escayg A, Bosmans F., ACS Chem Biol. May 16, 2014; 9 (5): 1204-12. |
|
A functional null mutation of SCN1B in a patient with Dravet syndrome., Patino GA, Claes LR, Lopez-Santiago LF, Slat EA, Dondeti RS, Chen C, O'Malley HA, Gray CB, Miyazaki H, Nukina N, Oyama F, De Jonghe P, Isom LL., J Neurosci. August 26, 2009; 29 (34): 10764-78. |
|
Mutations linked to generalized epilepsy in humans reduce GABA(A) receptor current., Macdonald RL, Bianchi MT, Bianch MT, Feng H., Exp Neurol. November 1, 2003; 184 Suppl 1 S58-67. |
???pagination.result.page??? 1